Astria Therapeutics Financial Overview
Astria Therapeutics's market cap is currently $740.39M. The company's EPS TTM is $-0.55; its P/E ratio is ―; Astria Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
